{"DataElement":{"publicId":"2689272","version":"4","preferredName":"Immune System Disorder Classification Type","preferredDefinition":"A description of the immune system disorder classification.","longName":"2689239v1.00:2689266v2.10","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2689239","version":"1","preferredName":"Immune System Disorder Classification","preferredDefinition":"A disorder resulting from an abnormality in the immune system. -- 2003_A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"IMNE_DZ_CLS","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2716886","version":"1","preferredName":"Immune System Disorder","preferredDefinition":"A disorder resulting from an abnormality in the immune system. -- 2003","longName":"C3507","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune System Disorder","conceptCode":"C3507","definition":"A disorder resulting from an abnormality in the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"41D26659-B10F-23DA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-12-21","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-12-21","modifiedBy":"ONEDATA","dateModified":"2007-12-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD2F5-9B10-39CF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2689266","version":"2.1","preferredName":"Immune System Disorder Type","preferredDefinition":"A disorder resulting from an abnormality in the immune system. -- 2003_Something distinguishable as an identifiable class based on common qualities.","longName":"IMNE_DZ_TP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SCID, T- B- NK-, Adenosine deaminase (ADA) deficiency","valueDescription":null,"ValueMeaning":{"publicId":"2593377","version":"1","preferredName":"Adenosine Deaminase Deficiency","longName":"2593377","preferredDefinition":"An autosomal recessive deficiency of the purine salvage enzyme adenosine deaminase which results in Severe Combined Immunodeficiency Disease (SCID).  The most common form of SCID, accounting for about 50% of autosomal recessive cases.  The first disease for which gene therapy was applied.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosine Deaminase Deficiency","conceptCode":"C3962","definition":"An autosomal recessive deficiency of the purine salvage enzyme adenosine deaminase which results in Severe Combined Immunodeficiency Disease (SCID).  The most common form of SCID, accounting for about 50% of autosomal recessive cases.  The first disease for which gene therapy was applied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2883B38F-10CD-4337-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-873E-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"SCID, T- B- NK-, Reticular dysgenesis","valueDescription":null,"ValueMeaning":{"publicId":"3326327","version":"1","preferredName":"Reticular Dysgenesis","longName":"3326327","preferredDefinition":"A rare severe combined immunodeficiency disorder characterized by congenital agranulocytosis, lymphoid tissue and thymic tissue hypoplasia, and lymphopenia. Both cellular and humoral immunities are absent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reticular Dysgenesis","conceptCode":"C27070","definition":"A rare severe combined immunodeficiency disorder characterized by congenital agranulocytosis, lymphoid tissue and thymic tissue hypoplasia, and lymphopenia. Both cellular and humoral immunities are absent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3862B52-B5B2-375A-E040-BB89AD436460","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"ONEDATA","dateModified":"2011-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-873F-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"SCID, T- B- NK+, RAG 1/2 deficiency","valueDescription":null,"ValueMeaning":{"publicId":"14679108","version":"1","preferredName":"Severe Combined Immunodeficiency due to RAG Deficiency","longName":"14679108v1.00","preferredDefinition":"A rare severe combined immunodeficiency disorder caused by null mutations in recombination activating gene (RAG) 1 or RAG2. It is associated with a lack of T and B cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency due to RAG Deficiency","conceptCode":"C203453","definition":"A rare severe combined immunodeficiency disorder caused by null mutations in recombination activating gene (RAG) 1 or RAG2. It is associated with a lack of T and B cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F268594-8738-1317-E063-731AD00AF4C9","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8740-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"SCID, T- B- NK+, DCLRE1C (Artemis) deficiency","valueDescription":null,"ValueMeaning":{"publicId":"7515394","version":"1","preferredName":"Severe Combined Immunodeficiency, Athabascan Type","longName":"7515394","preferredDefinition":"An autosomal recessive condition caused by mutation(s) in the DCLRE1C gene, encoding protein artemis. It is characterized by severe combined immunodeficiency that is T-cell negative, B-cell negative, NK-cell positive. Sensitivity to ionizing radiation and a high incidence of occurrence amongst the Athabascan Indians are also characteristic of this disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency, Athabascan Type","conceptCode":"C162694","definition":"An autosomal recessive condition caused by mutation(s) in the DCLRE1C gene, encoding protein artemis. It is characterized by severe combined immunodeficiency that is T-cell negative, B-cell negative, NK-cell positive. Sensitivity to ionizing radiation and a high incidence of occurrence amongst the Athabascan Indians are also characteristic of this disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4C95360-7A0A-23EA-E053-4EBD850A951D","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8741-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-29","deletedIndicator":"No"},{"value":"SCID, T- B- NK-, not otherwise specified","valueDescription":null,"ValueMeaning":{"publicId":"14679109","version":"1","preferredName":"Severe Combined Immunodeficiency with Absence of T, B, and NK Cells","longName":"14679109v1.00","preferredDefinition":"A severe combined immunodeficiency disorder that is associated with a lack of T, B, and NK cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency with Absence of T, B, and NK Cells","conceptCode":"C203455","definition":"A severe combined immunodeficiency disorder that is associated with a lack of T, B, and NK cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F268594-8739-1317-E063-731AD00AF4C9","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8743-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"SCID, not otherwise specified","valueDescription":null,"ValueMeaning":{"publicId":"2689269","version":"1","preferredName":"Not Otherwise Specified Severe Combined Immunodeficiency","longName":"2689269","preferredDefinition":"Not characterized in any other way.: X-linked or autosomal recessive disorder characterized by defects of both humoral and cell mediated immunity, resulting in low or absent antibody levels, leukopenia, marked susceptibility to infections, and early death.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Severe Combined Immunodeficiency","conceptCode":"C3472","definition":"X-linked or autosomal recessive disorder characterized by defects of both humoral and cell mediated immunity, resulting in low or absent antibody levels, leukopenia, marked susceptibility to infections, and early death.--2004","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4D8B63-E89F-0BB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8744-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Other SCID","valueDescription":null,"ValueMeaning":{"publicId":"3108329","version":"1","preferredName":"Other Severe Combined Immunodeficiency","longName":"3108329","preferredDefinition":"Different than the one(s) previously specified or mentioned.: X-linked or autosomal recessive disorder characterized by defects of both humoral and cell mediated immunity, resulting in low or absent antibody levels, leukopenia, marked susceptibility to infections, and early death.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Severe Combined Immunodeficiency","conceptCode":"C3472","definition":"X-linked or autosomal recessive disorder characterized by defects of both humoral and cell mediated immunity, resulting in low or absent antibody levels, leukopenia, marked susceptibility to infections, and early death.--2004","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88885973-0BEC-EC2B-E040-BB89AD432554","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"WHITES","dateCreated":"2010-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8745-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"CD40 ligand deficiency","valueDescription":null,"ValueMeaning":{"publicId":"3377507","version":"1","preferredName":"CD40 Ligand Deficiency","longName":"3377507","preferredDefinition":"Patients with the X-linked hyper IgM syndrome have a deficiency of a protein, CD40 ligand that is found on the surface of T-lymphocytes. As a consequence of the deficiency of this protein, their T-lymphocytes are unable to instruct B-lymphocytes to switch their production of gamma globulins from IgM to IgG and IgA. As a result, patients have decreased levels of IgG and IgA and normal or elevated levels of IgM. In addition, since CD40 ligand is important to other functions of T-lymphocytes, they also have a defect in some of the protective functions of their T-lymphocytes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD40 Ligand Deficiency","conceptCode":"C61244","definition":"Patients with the X-linked hyper IgM syndrome have a deficiency of a protein, CD40 ligand that is found on the surface of T-lymphocytes. As a consequence of the deficiency of this protein, their T-lymphocytes are unable to instruct B-lymphocytes to switch their production of gamma globulins from IgM to IgG and IgA. As a result, patients have decreased levels of IgG and IgA and normal or elevated levels of IgM. In addition, since CD40 ligand is important to other functions of T-lymphocytes, they also have a defect in some of the protective functions of their T-lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8E0919B-1304-9720-E040-BB89AD434D99","latestVersionIndicator":"Yes","beginDate":"2012-02-13","endDate":null,"createdBy":"NYCHM","dateCreated":"2012-02-13","modifiedBy":"ONEDATA","dateModified":"2012-02-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8746-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"DOCK8 Deficiency","valueDescription":null,"ValueMeaning":{"publicId":"5207250","version":"1","preferredName":"DOCK8 Deficiency","longName":"5207250","preferredDefinition":"A condition of decreased or absent presence or activity of dedicator of cytokinesis protein 8. Deficiency of this protein is associated with autosomal recessive hyper-IgE recurrent infection syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DOCK8 Deficiency","conceptCode":"C126343","definition":"A condition of decreased or absent presence or activity of dedicator of cytokinesis protein 8. Deficiency of this protein is associated with autosomal recessive hyper-IgE recurrent infection syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-4537-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8747-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"MHC Class II Deficiency (Bare lymphocyte syndrome)","valueDescription":null,"ValueMeaning":{"publicId":"3322393","version":"1","preferredName":"Bare Lymphocyte Syndrome","longName":"3322393","preferredDefinition":"A hereditary immunodeficiency disorder caused by the absence of major histocompatibility complex class II expression. Signs and symptoms include upper and lower respiratory tract bacterial infections, malabsorption, diarrhea, and mucocutaneous candidiasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bare Lymphocyte Syndrome","conceptCode":"C3895","definition":"A hereditary immunodeficiency disorder caused by the lack of expression of major histocompatibility complex (MHC) proteins. Signs include upper and lower respiratory tract bacterial infections, malabsorption, diarrhea, and mucocutaneous candidiasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BD18-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"ONEDATA","dateModified":"2011-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8748-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Omenn syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3323722","version":"1","preferredName":"Omenn Syndrome","longName":"3323722","preferredDefinition":"An autosomal recessive combined immunodeficiency syndrome caused by mutations in the RAG-1 and RAG-2 genes. It is characterized by the presence of alopecia, erythroderma, desquamation, lymphadenopathy, and chronic diarrhea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Omenn Syndrome","conceptCode":"C61240","definition":"An autosomal recessive combined immunodeficiency syndrome caused by mutations in the RAG-1 and RAG-2 genes. It is characterized by the presence of alopecia, erythroderma, desquamation, lymphadenopathy, and chronic diarrhea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B381BEF5-8345-6627-E040-BB89AD4359F7","latestVersionIndicator":"Yes","beginDate":"2011-12-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-07","modifiedBy":"ONEDATA","dateModified":"2011-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8749-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"ZAP-70 deficiency","valueDescription":null,"ValueMeaning":{"publicId":"7515579","version":"1","preferredName":"Immunodeficiency 48; Selective T-Cell Defect; STCD","longName":"7515579","preferredDefinition":"An autosomal recessive immunodeficiency caused by mutation(s) in the ZAP70 gene, encoding tyrosine-protein kinase ZAP-70. It is characterized by absent CD8+ cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency 48","conceptCode":"C176821","definition":"An autosomal recessive immunodeficiency caused by mutation(s) in the ZAP70 gene, encoding tyrosine-protein kinase ZAP-70. It is characterized by absent CD8+ cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-37A2-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-874A-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Ataxia telangiectasia","valueDescription":null,"ValueMeaning":{"publicId":"2593388","version":"1","preferredName":"Ataxia Telangiectasia Syndrome","longName":"2593388","preferredDefinition":"Rare hereditary disease characterized by extreme sensitivity to ionizing radiation or radiomimetic drugs because of a defect in DNA repair. AT heterozygosity is estimated to occur in more than 2% of the U.S. population; heterozygotes exhibit increased radiation sensitivity and are at increased risk for several types of cancer. The normal version of the gene that is defective in AT appears to activate the p53-dependent response to DNA damage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ataxia Telangiectasia Syndrome","conceptCode":"C2887","definition":"Rare hereditary disease characterized by extreme sensitivity to ionizing radiation or radiomimetic drugs because of a defect in DNA repair. AT heterozygosity is estimated to occur in more than 2% of the U.S. population; heterozygotes exhibit increased radiation sensitivity and are at increased risk for several types of cancer. The normal version of the gene that is defective in AT appears to activate the p53-dependent response to DNA damage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2883B655-AF9E-439B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-874B-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Cartilage-hair hypoplasia","valueDescription":null,"ValueMeaning":{"publicId":"3322411","version":"1","preferredName":"Cartilage Hair Hypoplasia","longName":"3322411","preferredDefinition":"A rare autosomal recessive inherited disorder caused by mutation in the gene for RNAase RMRP. It is characterized by short-limb dwarfism, presence of fine sparse hair, and T-and B-cell immunodeficiency.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cartilage Hair Hypoplasia","conceptCode":"C61245","definition":"A rare autosomal recessive inherited disorder caused by mutation in the gene for RNAase RMRP. It is characterized by short-limb dwarfism, presence of fine sparse hair, and T-and B-cell immunodeficiency.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BDAA-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-874C-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"DiGeorge anomaly","valueDescription":null,"ValueMeaning":{"publicId":"2593391","version":"1","preferredName":"DiGeorge Syndrome","longName":"2593391","preferredDefinition":"A congenital anomaly characterized by immunodeficiency, abnormal facies, congenital heart disease, hypocalcemia, and increased susceptibility to infections. Pathologic characteristics include conotruncal abnormalities and absence or hypoplasia of thymus and parathyroid glands. DiGeorge syndrome is associated with abnormalities of chromosome 22. Also known as DiGeorge anomaly. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"22q11.2 Deletion Syndrome","conceptCode":"C2989","definition":"A congenital anomaly characterized by immunodeficiency, abnormal facies, congenital heart disease, hypocalcemia, and increased susceptibility to infections. Pathologic characteristics include conotruncal abnormalities and absence or hypoplasia of thymus and parathyroid glands. DiGeorge syndrome is associated with abnormalities of chromosome 22. Also known as DiGeorge anomaly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28850FD4-AA29-5B37-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-874D-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"NEMO Deficiency Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14679110","version":"1","preferredName":"Ectodermal Dysplasia and Immunodeficiency 1","longName":"14679110v1.00","preferredDefinition":"An X-linked recessive condition caused by mutation(s) in the IKBKG gene, encoding NF-kappa-B essential modulator (NEMO). It is characterized by the onset of recurrent severe infections due to immunodeficiency in early infancy or in the first years of life. Affected individuals may present with ectodermal dysplasia, including conical incisors, hypo/anhidrosis, and thin skin or hair.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ectodermal Dysplasia and Immunodeficiency 1","conceptCode":"C176592","definition":"An X-linked recessive condition caused by mutation(s) in the IKBKG gene, encoding NF-kappa-B essential modulator (NEMO). It is characterized by the onset of recurrent severe infections due to immunodeficiency in early infancy or in the first years of life. Affected individuals may present with ectodermal dysplasia, including conical incisors, hypo/anhidrosis, and thin skin or hair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F268594-873A-1317-E063-731AD00AF4C9","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-874E-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Wiskott-Aldrich syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2579850","version":"1","preferredName":"Wiskott-Aldrich syndrome","longName":"2579850","preferredDefinition":"A rare, X-linked immunodeficiency syndrome characterized by eczema, thrombocytopenia, and recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IgM levels are low and IgA and IgE levels are elevated. Lymphoreticular malignancies are common.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Wiskott-Aldrich Syndrome","conceptCode":"C3448","definition":"A rare, X-linked immunodeficiency syndrome characterized by eczema, thrombocytopenia, and recurrent pyogenic infection. It is seen exclusively in young boys. Typically, IgM levels are low and IgA and IgE levels are elevated. Lymphoreticular malignancies are common.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-874F-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Common variable immunodeficiency","valueDescription":null,"ValueMeaning":{"publicId":"2579841","version":"1","preferredName":"Common Variable Immunodeficiency","longName":"2579841","preferredDefinition":"A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Variable Immunodeficiency","conceptCode":"C26725","definition":"A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04EE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition to use current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8750-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Activated PI3 Kinase Delta Deficiency Syndrome (APDS1 or PIK3CD)","valueDescription":null,"ValueMeaning":{"publicId":"14679111","version":"1","preferredName":"Activated PI3K Delta Syndrome","longName":"14679111v1.00","preferredDefinition":"A rare, autosomal dominant inherited primary immunodeficiency disorder caused by mutations in either PIK3CD gene or PIK3R1 gene. Clinical manifestations include the following: recurrent respiratory tract infections; non-malignant lymphoproliferation that results in generalized lymphadenopathy and hepatosplenomegaly; chronic infections with Epsteinï¿½Barr virus, cytomegalovirus, and herpes simplex virus; cytopenia; and glomerulonephritis. Patients are at an increased risk of developing non-Hodgkin or Hodgkin lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activated PI3K Delta Syndrome","conceptCode":"C203458","definition":"A rare, autosomal dominant inherited primary immunodeficiency disorder caused by mutations in either PIK3CD gene or PIK3R1 gene. Clinical manifestations include the following: recurrent respiratory tract infections; non-malignant lymphoproliferation that results in generalized lymphadenopathy and hepatosplenomegaly; chronic infections with Epstein-Barr virus, cytomegalovirus, and herpes simplex virus; cytopenia; and glomerulonephritis. Patients are at an increased risk of developing non-Hodgkin or Hodgkin lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F268594-873B-1317-E063-731AD00AF4C9","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8751-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Chediak-Higashi syndrome","valueDescription":null,"ValueMeaning":{"publicId":"4308161","version":"1","preferredName":"Chediak-Higashi Syndrome","longName":"4308161","preferredDefinition":"A rare autosomal recessive immunodeficiency disorder characterized by abnormal intracellular protein transport. Chediak-Higashi syndrome (CHS) is characterized by immune deficiency; partial oculocutaneous albinism; a bleeding disorder due to deficient platelet dense bodies; neutropenia; neutrophils with impaired chemotaxis and bactericidal activity; recurrent infection; and abnormal natural killer (NK) cell function. CHS may be associated with hepatosplenomegaly, lymphadenopathy, anemia, thrombocytopenia, roentgenologic changes in bones, lungs and heart, and skin and psychomotor abnormalities; it is often fatal in childhood as a result of infection or an accelerated lymphoma-like phase. CHS occurs in mink, cattle, and mice, as well as man.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chediak-Higashi Syndrome","conceptCode":"C2941","definition":"A rare autosomal recessive immunodeficiency disorder characterized by abnormal intracellular protein transport. Chediak-Higashi syndrome (CHS) is characterized by immune deficiency; partial oculocutaneous albinism; a bleeding disorder due to deficient platelet dense bodies; neutropenia; neutrophils with impaired chemotaxis and bactericidal activity; recurrent infection; and abnormal natural killer (NK) cell function. CHS may be associated with hepatosplenomegaly, lymphadenopathy, anemia, thrombocytopenia, roentgenologic changes in bones, lungs and heart, and skin and psychomotor abnormalities; it is often fatal in childhood as a result of infection or an accelerated lymphoma-like phase. CHS occurs in mink, cattle, and mice, as well as man.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E0A14-6B3C-74D0-E040-BB89AD433449","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8752-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Griscelli syndrome type 2","valueDescription":null,"ValueMeaning":{"publicId":"3940912","version":"1","preferredName":"Griscelli Syndrome Type 2","longName":"3940912","preferredDefinition":"A rare, autosomal recessive genetic syndrome caused by mutations in the RAB27A gene.  It is characterized by hypopigmentation of the skin, hair and eyes, recurrent infections, neutropenia, and immune system abnormalities.  Patients are prone to develop hemophagocytic lymphohistiocytosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Griscelli Syndrome Type 2","conceptCode":"C111814","definition":"A rare, autosomal recessive genetic syndrome caused by mutations in the RAB27A gene.  It is characterized by hypopigmentation of the skin, hair and eyes, recurrent infections, neutropenia, and immune system abnormalities.  Patients are prone to develop hemophagocytic lymphohistiocytosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA08B251-5CA6-ED4B-E040-BB89AD4371A4","latestVersionIndicator":"Yes","beginDate":"2013-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8753-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Hermansky-Pudlak syndrome type 2","valueDescription":null,"ValueMeaning":{"publicId":"14679112","version":"1","preferredName":"Hermansky-Pudlak Syndrome 2","longName":"14679112v1.00","preferredDefinition":"An autosomal recessive sub-type of Hermansky-Pudlak syndrome caused by mutation(s) in the AP3B1 gene, encoding AP-3 complex subunit beta-1. Immunodeficiency due to neutropenia is a characteristic of this sub-type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hermansky-Pudlak Syndrome 2","conceptCode":"C150368","definition":"An autosomal recessive sub-type of Hermansky-Pudlak syndrome caused by mutation(s) in the AP3B1 gene, encoding AP-3 complex subunit beta-1. Immunodeficiency due to neutropenia is a characteristic of this sub-type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F268594-873C-1317-E063-731AD00AF4C9","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8754-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Other pigmentary dilution disorder","valueDescription":null,"ValueMeaning":{"publicId":"4308160","version":"1","preferredName":"Other Reduced Pigmentation Disease or Disorder","longName":"4308160","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Made less in size or amount or degree.: Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Reduced","conceptCode":"C25640","definition":"Made less in size or amount or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pigmentation","conceptCode":"C38005","definition":"Pigmentation; the coloring of the skin, hair, mucous membranes, and retina of the eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F94E0A14-6B05-74D0-E040-BB89AD433449","latestVersionIndicator":"Yes","beginDate":"2014-05-13","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8755-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"SAP deficiency (XIAP-1)","valueDescription":null,"ValueMeaning":{"publicId":"7515582","version":"1","preferredName":"X-linked Lymphoproliferative Syndrome 1","longName":"7515582","preferredDefinition":"An X-linked recessive condition caused by mutation(s) in the SH2D1A gene, encoding SH2 domain-containing protein 1A. It is characterized by a susceptibility to severe EBV infection, acquired hypogammaglobulinemia, hemophagocytic lymphohistiocytosis, and/or lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-linked Lymphoproliferative Syndrome 1","conceptCode":"C170434","definition":"An X-linked recessive condition caused by mutation(s) in the SH2D1A gene, encoding SH2 domain-containing protein 1A. It is characterized by a susceptibility to severe EBV infection, acquired hypogammaglobulinemia, hemophagocytic lymphohistiocytosis, and/or lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3820-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8756-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"XIAP-2 deficiency","valueDescription":null,"ValueMeaning":{"publicId":"5189572","version":"1","preferredName":"XIAP Deficiency","longName":"5189572","preferredDefinition":"A condition of decreased or absent presence of baculoviral IAP repeat-containing protein 4. Deficiency of this protein is associated with X-linked lymphoproliferative syndrome 2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-linked Lymphoproliferative Syndrome 2","conceptCode":"C126295","definition":"An X-linked lymphoproliferative disorder caused by mutations in the XIAP gene. Clinical manifestations include hemophagocytic lymphohistiocytosis (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. Patients are at an increased risk of developing lymphoma, typically B-cell non-Hodgkin lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2EA23415-22C1-8B50-E050-BB89AD4351B0","latestVersionIndicator":"Yes","beginDate":"2016-03-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8757-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"ITK deficiency","valueDescription":null,"ValueMeaning":{"publicId":"5207248","version":"1","preferredName":"ITK Deficiency","longName":"5207248","preferredDefinition":"A condition of decreased or absent presence or activity of IL2-inducible t-cell kinase. Deficiency of this protein is associated with lymphoproliferative syndrome 1, an autosomal recessive primary immunodeficiency characterized by onset in early childhood of Epstein-Barr virus (EBV)-associated immune dysregulation, manifest as lymphoma, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis, Hodgkin disease, and/or hypogammaglobulinemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoproliferative Syndrome 1","conceptCode":"C126344","definition":"An autosomal recessive immunodeficiency caused but mutation(s) in the ITK gene, encoding tyrosine-protein kinase ITK/TSK. It is characterized by the early childhood onset of Epstein-Barr virus (EBV)-associated immune dysregulation leading to lymphoma, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis, and/or hypogammaglobulinemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-44ED-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8758-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Autoimmune Lymphoproliferative Syndrome (ALPS)","valueDescription":null,"ValueMeaning":{"publicId":"3210890","version":"1","preferredName":"Autoimmune Lymphoproliferative Syndrome","longName":"3210890","preferredDefinition":"An autoimmune hematologic disorder characterized by autoimmune hemolytic anemia, thrombocytopenia, lymphadenopathy, hepatomegaly and splenomegaly. Patients are at an increased risk of developing Hodgkin and non-Hodgkin lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Lymphoproliferative Syndrome","conceptCode":"C37864","definition":"An autoimmune hematologic disorder characterized by autoimmune hemolytic anemia, thrombocytopenia, lymphadenopathy, hepatomegaly and splenomegaly. Patients are at an increased risk of developing Hodgkin and non-Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B040-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8759-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"CTLA4 deficiency","valueDescription":null,"ValueMeaning":{"publicId":"5207234","version":"1","preferredName":"CTLA4 Haploinsufficiency; CHAI; ALPS5","longName":"5207234","preferredDefinition":"A somatic mutation in the CTLA4 gene resulting in only a single functional gene. Haploinsufficiency for CTLA4 is associated with autoimmune lymphoproliferative syndrome, type V.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CTLA4 Deficiency","conceptCode":"C126341","definition":"A genetic condition caused by mutation(s) in the CTLA4 gene, encoding cytotoxic T-lymphocyte protein 4. Cytotoxic T-lymphocyte protein 4 is an inhibitory receptor acting as a negative regulator of T-cells, and two functional copies of the gene are required for normal immune function. Clinically, it may be characterized by gastrointestinal symptoms, lymphadenopathy, hepatomegaly, and splenomegaly, and autoimmune disorders. Mutations(s) in CTLA4 are also associated with autoimmune lymphoproliferative syndrome, type V.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-4411-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-875A-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"IPEX, Immune Dysregulation Polyendocrinopathy, enteropathy X-linked (FOXP3 deficiency)","valueDescription":null,"ValueMeaning":{"publicId":"7515612","version":"1","preferredName":"Immune Dysregulation, Polyendocrinopathy, and Enteropathy X-Linked Syndrome","longName":"7515612","preferredDefinition":"An X-linked recessive autoimmune condition caused by mutation(s) in the FOXP3 gene, encoding the forkhead box P3 transcription factor. The condition is characterized by infantile onset of severe diarrhea due to enteropathy, type 1 diabetes mellitus, and dermatitis. Associated features may include hypothyroidism, autoimmune hemolytic anemia, thrombocytopenia, lymphadenopathy, hepatitis, and nephritis. The condition is usually fatal before age 2 years if not treated with bone marrow transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune Dysregulation, Polyendocrinopathy, and Enteropathy X-Linked Syndrome","conceptCode":"C131009","definition":"An X-linked recessive autoimmune condition caused by mutation(s) in the FOXP3 gene, encoding the forkhead box P3 transcription factor. The condition is characterized by infantile onset of severe diarrhea due to enteropathy, type 1 diabetes mellitus, and dermatitis. Associated features may include hypothyroidism, autoimmune hemolytic anemia, thrombocytopenia, lymphadenopathy, hepatitis, and nephritis. The condition is usually fatal before age 2 years if not treated with bone marrow transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3C90-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"ONEDATA","dateModified":"2020-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-875B-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"LRBA Deficiency","valueDescription":null,"ValueMeaning":{"publicId":"7515605","version":"1","preferredName":"Immunodeficiency, Common Variable, 8, with Autoimmunity","longName":"7515605","preferredDefinition":"An autosomal recessive common variable immunodeficiency caused by mutation(s) in the LRBA gene, encoding lipopolysaccharide-responsive and beige-like anchor protein. It is characterized by recurrent infections and the development of autoimmune disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency, Common Variable, 8, with Autoimmunity","conceptCode":"C176809","definition":"An autosomal recessive common variable immunodeficiency caused by mutation(s) in the LRBA gene, encoding lipopolysaccharide-responsive and beige-like anchor protein. It is characterized by recurrent infections and the development of autoimmune disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3BA6-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-875C-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"STAT3 Gain of Function","valueDescription":null,"ValueMeaning":{"publicId":"5207241","version":"1","preferredName":"STAT3 Gain of Function","longName":"5207241","preferredDefinition":"A mutation in the STAT3 gene that results in an increase in cytokine-related function. STAT3 mutations of this type are associated with infantile-onset multisystem autoimmune disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating STAT3 Gene Mutation","conceptCode":"C126345","definition":"A mutation in the STAT3 gene that results in an increase in cytokine-related function. STAT3 mutations of this type are associated with infantile-onset multisystem autoimmune disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F4A7CBE-8FF5-418E-E050-BB89AD43061D","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-875D-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Chronic granulomatous disease","valueDescription":null,"ValueMeaning":{"publicId":"2579840","version":"1","preferredName":"chronic granulomatous disease","longName":"2579840","preferredDefinition":"A recessive X-linked defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Granulomatous Disease","conceptCode":"C26788","definition":"A rare genetic disorder with a predominantly X-linked recessive pattern of inheritance resulting in impaired phagocytic clearance of bacteria and fungi. It is caused by a defect in the phagocytic NADPH oxidase (phox) complex. The phagocytes can engulf pathogens but are unable to produce the microbicidal precursors needed to destroy them. Clinical signs of severe disease present in childhood with milder forms later in life. They include recurrent infection especially pneumonia, cervical lymphadenopathy and hepatosplenomegaly. The clinical course includes the appearance of granulomata in the skin and gastrointestinal or genitourinary tracts. The clinical prognosis is dependent on effectively treating and preventing infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04ED-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-875E-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"GATA2 deficiency","valueDescription":null,"ValueMeaning":{"publicId":"5207249","version":"1","preferredName":"GATA2 Deficiency","longName":"5207249","preferredDefinition":"A condition of decreased or absent presence or activity of endothelial transcription factor GATA-2 protein. Deficiency of this protein is associated with immunodeficiency 21 and autosomal dominant and sporadic monocytopenia and mycobacterial infection syndrome (MonoMAC).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"GATA2 Deficiency","conceptCode":"C126349","definition":"A condition of decreased or absent presence or activity of endothelial transcription factor GATA-2 protein. Deficiency of this protein is associated with immunodeficiency 21 and autosomal dominant and sporadic monocytopenia and mycobacterial infection syndrome (MonoMAC).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F499E09-4512-CF28-E050-BB89AD4321FA","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-875F-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Leukocyte adhesion deficiencies","valueDescription":null,"ValueMeaning":{"publicId":"3323201","version":"1","preferredName":"Leukocyte Adhesion Deficiency","longName":"3323201","preferredDefinition":"A rare autosomal recessive immunodeficiency disorder caused by deficiency of CD18 expression. It is characterized by defects in neutrophil adhesion and bacterial infections.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukocyte Adhesion Deficiency","conceptCode":"C27874","definition":"A rare autosomal recessive immunodeficiency disorder caused by deficiency of CD18 expression. It is characterized by defects in neutrophil adhesion and bacterial infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3724AB2-AF9A-5E8E-E040-BB89AD433884","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8760-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Neutropenia with combined immune deficiency (MKL1 deficiency, Actin deficiency)","valueDescription":null,"ValueMeaning":{"publicId":"14679113","version":"1","preferredName":"Immunodeficiency 66","longName":"14679113v1.00","preferredDefinition":"An autosomal recessive combined immunodeficiency caused by mutation(s) in the MRTFA (MKL1) gene, encoding myocardin-related transcription factor A. It is characterized by neutropenia and recurrent bacterial infections in infancy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunodeficiency 66","conceptCode":"C203465","definition":"An autosomal recessive combined immunodeficiency caused by mutation(s) in the MRTFA (MKL1) gene, encoding myocardin-related transcription factor A. It is characterized by neutropenia and recurrent bacterial infections in infancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F268594-873D-1317-E063-731AD00AF4C9","latestVersionIndicator":"Yes","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8761-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"STAT1 Gain of Function","valueDescription":null,"ValueMeaning":{"publicId":"5207240","version":"1","preferredName":"STAT1 Gain of Function","longName":"5207240","preferredDefinition":"A mutation in the STAT1 gene that results in an increase in cytokine-related functions associated with IFN-alpha/beta, IFN-gamma, IFN-delta, and IL-27. STAT1 mutations of this type are associated with autosomal dominant immunodeficiency 31C.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Activating STAT1 Gene Mutation","conceptCode":"C126346","definition":"A mutation in the STAT1 gene that results in an increase in cytokine-related functions associated with IFN-alpha/beta, IFN-gamma, IFN-delta, and IL-27. STAT1 mutations of this type are associated with autosomal dominant immunodeficiency 31C.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F4A7CBE-8FD0-418E-E050-BB89AD43061D","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8762-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Other immunodeficiencies","valueDescription":null,"ValueMeaning":{"publicId":"3929631","version":"1","preferredName":"Other Immunodeficiency Syndrome","longName":"3929631","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9815BD1-1E00-6C8D-E040-BB89AD430CA0","latestVersionIndicator":"Yes","beginDate":"2013-10-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8763-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"HIV infection","valueDescription":null,"ValueMeaning":{"publicId":"2579838","version":"1","preferredName":"HIV infection","longName":"2579838v1.00","preferredDefinition":"An infection caused by the human immunodeficiency virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HIV Infection","conceptCode":"C3108","definition":"An infection caused by the human immunodeficiency virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04EB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8764-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Immune deficiency, not otherwise specified","valueDescription":null,"ValueMeaning":{"publicId":"2689273","version":"1","preferredName":"Not Otherwise Specified Immunodeficiency Syndrome","longName":"2689273","preferredDefinition":"Not characterized in any other way.: A deficiency of immune response or a disorder characterized by deficient immune response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immunodeficiency Syndrome","conceptCode":"C3131","definition":"Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4DAAFB-3627-27A1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F268594-8765-1317-E063-731AD00AF4C9","beginDate":"2024-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","deletedIndicator":"No"},{"value":"Hemophagocytosis","valueDescription":null,"ValueMeaning":{"publicId":"2579881","version":"1","preferredName":"hemophagocytosis","longName":"2579881","preferredDefinition":"The term hemophagocytosis describes the pathologic finding of activated macrophages, engulfing erythrocytes, leukocytes, platelets, and their precursor cells. (from Medscape: Hemophagocytic Syndromes and Infection)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemophagocytosis","conceptCode":"C35985","definition":"The term hemophagocytosis describes the pathologic finding of activated macrophages, engulfing erythrocytes, leukocytes, platelets, and their precursor cells. (from Medscape: Hemophagocytic Syndromes and Infection)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0516-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10178675-0F6E-475D-E063-731AD00A0B07","beginDate":"2024-01-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-29","modifiedBy":"KUMMEROA","dateModified":"2024-01-29","deletedIndicator":"No"},{"value":"SCID, T- B+ NK-, JAK3 mutation","valueDescription":null,"ValueMeaning":{"publicId":"7515608","version":"1","preferredName":"Severe Combined Immunodeficiency, Autosomal Recessive, T-Cell Negative, B-Cell Positive, NK-Cell Negative","longName":"7515608","preferredDefinition":"An autosomal recessive severe combined immunodeficiency caused by mutation(s) in the JAK3 gene, encoding tyrosine-protein kinase JAK3. It is characterized by decreased concentrations of T-cells and NK-cells and normal concentrations of B-cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Combined Immunodeficiency, Autosomal Recessive, T-Cell Negative, B-Cell Positive, NK-Cell Negative","conceptCode":"C176807","definition":"An autosomal recessive severe combined immunodeficiency caused by mutation(s) in the JAK3 gene, encoding tyrosine-protein kinase JAK3. It is characterized by decreased concentrations of T-cells and NK-cells and normal concentrations of B-cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3C0F-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10672D06-1A32-60BD-E063-731AD00A061E","beginDate":"2024-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-02-02","modifiedBy":"KUMMEROA","dateModified":"2024-02-02","deletedIndicator":"No"},{"value":"SCID, T- B+ NK-, IL2RG mutations, X-linked SCID","valueDescription":null,"ValueMeaning":{"publicId":"7515583","version":"1","preferredName":"X-Linked Severe Combined Immunodeficiency","longName":"7515583","preferredDefinition":"Rare congenital disorder inherited as an X-linked defect characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Linked Severe Combined Immunodeficiency","conceptCode":"C4682","definition":"Rare congenital disorder inherited as an X-linked defect characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B4CA2F53-3843-5B2F-E053-4EBD850A1513","latestVersionIndicator":"Yes","beginDate":"2020-11-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2020-11-23","modifiedBy":"KUMMEROA","dateModified":"2021-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10672D06-1A33-60BD-E063-731AD00A061E","beginDate":"2024-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-02-02","modifiedBy":"KUMMEROA","dateModified":"2024-02-02","deletedIndicator":"No"},{"value":"SCID,T- B+ NK+, ILR alpha deficiency","valueDescription":null,"ValueMeaning":{"publicId":"14741328","version":"1","preferredName":"IL-7R-Alpha-deficient Severe Combined Immunodeficiency","longName":"14741328v1.00","preferredDefinition":"An autosomal recessive form of severe combined immunodeficiency characterized as t-cell negative, b-cell positive, NK cell positive, and with mutations in the gene encoding interleukin-7 receptor alpha chain protein. This class of SCID accounts for approximately 10% of all SCID cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IL-7R-Alpha-deficient Severe Combined Immunodeficiency","conceptCode":"C203825","definition":"An autosomal recessive form of severe combined immunodeficiency characterized as t-cell negative, b-cell positive, NK cell positive, and with mutations in the gene encoding interleukin-7 receptor alpha chain protein. This class of SCID accounts for approximately 10% of all SCID cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"10672D06-1A31-60BD-E063-731AD00A061E","latestVersionIndicator":"Yes","beginDate":"2024-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-02-02","modifiedBy":"KUMMEROA","dateModified":"2024-02-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"10672D06-1A34-60BD-E063-731AD00A061E","beginDate":"2024-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-02-02","modifiedBy":"KUMMEROA","dateModified":"2024-02-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2486864","version":"1","preferredName":"Immune System Disorder Type","preferredDefinition":"A disorder resulting from an abnormality in the immune system. -- 2003:Type; a subdivision of a particular kind of thing.","longName":"C3507:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune System Disorder","conceptCode":"C3507","definition":"A disorder resulting from an abnormality in the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1647C1A9-97C8-2D88-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-15","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-15","modifiedBy":"ONEDATA","dateModified":"2006-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"DRAFT MOD","registrationStatus":"Application","id":"0F26430E-F5D2-03DD-E063-731AD00A2692","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-02-02","changeDescription":"Updated PV to remove special characters for MDR data migration. 3.26.20 smt","administrativeNotes":"2024.2.2 PVs added per ticket request CADSR0003337. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964897","version":"1","longName":"2031r1: Immune Deficiencies Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"pre_ted_who_immune_defic","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_immune_sys_class","type":"NMDP_FN","context":"NHLBI"},{"name":"id_base_imun_def_phenotyp","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"CPRE_ICT_immune_sys_class","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_DIS_immune_sys_class","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the classification of the immune deficiency?","url":null,"context":"NHLBI"},{"name":"What is the immune deficiency phenotype?","type":"Alternate Question Text","description":"What is the immune deficiency phenotype?","url":null,"context":"NHLBI"},{"name":"Specify disorder of immune system classification","type":"Alternate Question Text","description":"Specify disorder of immune system classification","url":null,"context":"NHLBI"},{"name":"Specify disorder of immune system classification","type":"Application Standard Question Text","description":"Specify disorder of immune system classification","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"DRAFT MOD","registrationStatus":"Application","id":"0F26893B-E94B-13E2-E063-731AD00A5A68","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2024-01-17","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":"Versioned due to adding many PVs. System generated def displayed as alt def. AK 3/30/16","administrativeNotes":"2024.1.17 Created per ticket request CADSR0003263. ak","unresolvedIssues":null,"deletedIndicator":"No"}}